Cardio toxicity for older breast cancer patients treated with trastuzumab

被引：0
|
作者：
Bensalem, A. [1 ]
Hamdouche, R. [1 ]
Bensehamdi, A. [1 ]
Boudersa, A. [1 ]
Yousfi, N. [1 ]
Bouzid, K. [2 ]
机构：
[1] CHU Dr Benbadis Constantine Algeria, CNE, Constantine, Algeria
[2] CPMC, Algiers, Algeria
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1568
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [21] Incidence, Diagnosis, and Treatment of Cardiac Toxicity From Trastuzumab in Patients With Breast Cancer
    Nowsheen S.
    Viscuse P.V.
    O’Sullivan C.C.
    Sandhu N.P.
    Haddad T.C.
    Blaes A.
    Klemp J.
    Nhola L.
    Herrmann J.
    Ruddy K.J.
    Current Breast Cancer Reports, 2017, 9 (3) : 173 - 182
  • [22] CARDIAC TOXICITY IN PATIENTS WITH BREAST CANCER UNDERGOING CONCOMITANT RADIOTHERAPY AND TRASTUZUMAB.
    Garcia Reglero, V.
    Colomer, M.
    Aguirre, E.
    Mira Flores, M.
    Monfa Binefa, C.
    Garcia Alonso, E.
    Baquedano Baquedano, J. E.
    Ripol
    Carceller, J. A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S296 - S296
  • [23] Trastuzumab-related cardiotoxicity among older breast cancer patients.
    Chavez-Mac Gregor, Mariana
    Zhang, Ning
    Buchholz, Thomas A.
    Zhang, Yufeng
    Niu, Jiangong
    Elting, Linda S.
    Hortobagyi, Gabriel N.
    Giordano, Sharon Hermes
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Cardio-toxicity in breast cancer - Prevention and therapy
    Schumacher, K.
    Muscholl, M.
    Zuern, C.
    Grischke, E. -M.
    Fehm, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (11) : 1034 - 1036
  • [25] Differential effect of anthracycline and trastuzumab cancer therapeutic related vascular toxicity in patients with breast cancer
    Anastasiou, M.
    Oikonomou, E.
    Vogialzi, G.
    Siasos, G.
    Flora, Z.
    Antonopoulos, A. S.
    Tsalamandris, S.
    Bamias, A.
    Dimopoulos, M. A.
    Tousoulis, D.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3287 - 3287
  • [26] SERIAL ECHOCARDIOGRAPHY FOR EARLY DIAGNOSIS OF CARDIOTOXICITY IN BREAST CANCER PATIENTS TREATED WITH TRASTUZUMAB
    Shah, F.
    Silverman, D.
    Doloto, P.
    Micetich, K. C.
    Barron, J. T.
    CARDIOLOGY, 2014, 128 : 417 - 417
  • [27] Cardiotoxicity in HER2 positive breast cancer patients treated with trastuzumab
    Lopez, M.
    Minguito Carazo, C.
    Delgado Sillero, I.
    Rojas Piedra, M.
    Tavara Silva, B.
    Lopez-Gonzalez, A.
    Castanon Lopez, C.
    Nieto Mangudo, B.
    Pedraza Lorenzo, M.
    Rodriguez Sanchez, A.
    Diz Tain, P.
    De Sande Gonzalez, L. M.
    Medina Valdivieso, S.
    Lopez Gonzalez, L.
    Honrado Franco, E.
    Garcia-Palomo, A.
    Sanchez-Cousido, L. F.
    ANNALS OF ONCOLOGY, 2020, 31 : S332 - S332
  • [28] Characterization of time toxicity in older patients with metastatic breast cancer
    Atre, Swarali Y.
    Soulos, Pamela R.
    Kuderer, Nicole M.
    Gross, Cary P.
    Baum, Laura V. M.
    Dinan, Michaela A.
    Lustberg, Maryam B.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 207 (03) : 541 - 550
  • [29] Central nervous system metastases in advanced breast cancer patients treated with trastuzumab
    Duchnowska, Renata
    Szczylik, Cezary
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (02): : 51 - 56
  • [30] Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine
    Modi, Natansh D.
    Sorich, Michael J.
    Rowland, Andrew
    McKinnon, Ross A.
    Koczwara, Bogda
    Wiese, Michael D.
    Hopkins, Ashley M.
    CLINICAL BREAST CANCER, 2020, 20 (02) : E220 - +
12345